表紙
市場調查報告書

眼科用醫藥品的全球市場:抗青光眼藥·乾眼症治療藥·其他 (視網膜障礙·抗感染疾病藥/過敏)

Ophthalmology Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery

出版商 The Business Research Company 商品編碼 531334
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
眼科用醫藥品的全球市場:抗青光眼藥·乾眼症治療藥·其他 (視網膜障礙·抗感染疾病藥/過敏) Ophthalmology Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery
出版日期: 2020年05月19日內容資訊: 英文
簡介

本報告提供全球眼科用醫藥品的市場調查,提供市場定義和概要,市場的各種影響因素分析,各藥物部門·各地各國趨勢與市場規模的變化與預測,並彙整與宏觀經濟因素·醫療保健市場全體·各種產業指標的比較,競爭環境,企業簡介等資料。

第1章 市場特徵

第2章 市場規模·成長率

  • 市場成長:迄今的過程
    • 成長推進因素
    • 阻礙成長要素
  • 市場成長:預測
    • 成長推進因素
    • 阻礙成長要素

第3章 大環境分析

第4章 客戶資訊

第5章 眼科用醫藥品市場分析:各種類

  • 全球市場的實際成果:各種類
    • 抗青光眼藥
    • 乾眼症治療藥
    • 其他
      • 視網膜障礙
      • 抗感染疾病藥/過敏
  • 全球市場的變化與預測:各種類
  • 市場趨勢·策略

第6章 眼科用醫藥品市場分析:各地各國分析

  • 全球市場的實際成果:各地區
  • 全球市場的變化與預測:各地區
  • 市場實際成果:各國
  • 市場變化與預測:各國
  • 全球醫藥品市場實際成果:部門·各地區
  • 全球醫藥品市場實際成果:部門·各國

第7章 宏觀經濟因素與市場比較

  • 市場規模的佔 GDP的百分比
  • 平均每個人的平均支出額

第8章 宏觀經濟因素與市場比較:各國

  • 市場規模的佔 GDP的百分比:各國
  • 平均每個人的平均支出額:各國

第9章 產業指標與市場比較

  • 全球藥劑師數:各國
  • 市場收益 vs 藥劑師數:各國
  • 全球醫藥品公司數:各國
  • 市場收益 vs 醫藥品公司數:各國
  • 全球對R&D/產品開發的平均支出額:各國
  • 市場收益 vs 對R&D/產品開發的平均支出額:各國
  • 全球非專利&品牌銷售額的比例:各國
  • 市場收益 vs 非專利&品牌銷售額的比例:各國
  • 青光眼的患病人數:各國

第10章 亞太地區市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 中國
  • 印度
  • 日本
  • 澳洲

第11章 西歐市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙

第12章 東歐市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 俄羅斯

第13章 北美市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 美國

第14章 南美市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 巴西

第15章 中東市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類

第16章 非洲市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類

第17章 競爭環境

  • 企業簡介
  • Novartis Ag
  • Regeneron
  • Allergan
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc.

第18章 主要M&A:眼科用醫藥品市場

第19章 市場背景:醫藥品市場

第20章 醫藥品產業的Financial Margins

第21章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

‘Ophthalmology Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery ’ from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global ophthalmology drugs market as it emerges from the Covid 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the ophthalmology drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Ophthalmology Drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider ophthalmology drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The ophthalmology drugs market section of the report gives context. It compares the ophthalmology drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, ophthalmology drugs indicators comparison.

Scope

Markets Covered:

1) By Type: Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others

3) By Route Of Administration: Oral; Parenteral; Others

4) By Drug Classification: Branded Drugs; Generic Drugs

5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Companies Mentioned: Novartis AG; F. Hoffmann-La Roche Ltd; Allergan Plc; Valeant Pharmaceuticals Intl Inc; Bayer AG

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, ophthalmology drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Report Structure

3. Ophthalmology Drugs Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Ophthalmology Drugs Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Ophthalmology Drugs Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Ophthalmology Drugs Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Ophthalmology Drugs Market Trends And Strategies

8. Ophthalmology Drugs Market Size And Growth

  • 8.1. Market Size
  • 8.2. Historic Market Growth, Value ($ Billion)
    • 8.2.1. Drivers Of The Market
    • 8.2.2. Restraints On The Market
  • 8.3. Forecast Market Growth, Value ($ Billion)
    • 8.3.1. Drivers Of The Market
    • 8.3.2. Restraints On The Market

9. Ophthalmology Drugs Market Regional Analysis

  • 9.1. Global Ophthalmology Drugs Market, 2019, By Region, Value ($ Billion)
  • 9.2. Global Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • 9.3. Global Ophthalmology Drugs Market, Growth And Market Share Comparison, By Region

10. Ophthalmology Drugs Market Segmentation

  • 10.1. Global Ophthalmology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Antiglaucoma Drugs

Dry Eye Medication

Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)

  • 10.2. Global Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Hospital Pharmacies

Retail Pharmacies/ Drug Stores

Others

  • 10.3. Global Ophthalmology Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Oral

Parenteral

Others

  • 10.4. Global Ophthalmology Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Branded Drugs

Generic Drugs

  • 10.5. Global Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Prescription-Based Drugs

Over-The-Counter Drugs

11. Ophthalmology Drugs Market Metrics

  • 11.1. Ophthalmology Drugs Market Size, Percentage Of GDP, 2015-2023, Global
  • 11.2. Per Capita Average Ophthalmology Drugs Market Expenditure, 2015-2023, Global

12. Asia-Pacific Ophthalmology Drugs Market

  • 12.1. Asia-Pacific Ophthalmology Drugs Market Overview
  • 12.2. Asia-Pacific, Ophthalmology Drugs Market, 2019, By Country, Value ($ Billion)
  • 12.3. Asia-Pacific, Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 12.4. Asia-Pacific, Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 12.5. Asia-Pacific, Ophthalmology Drugs Market Metrics
    • 12.5.1. Per Capita Average Ophthalmology Drugs Expenditure, 2015-2023, Asia-Pacific Countries
  • 12.6. Asia-Pacific Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 12.7. Asia-Pacific Ophthalmology Drugs Market: Country Analysis
    • 12.7.1. China Ophthalmology Drugs Market
      • 12.7.1.1. China Ophthalmology Drugs Market Overview
      • 12.7.1.2. China Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.1.3. China Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.2. Australia Ophthalmology Drugs Market
      • 12.7.2.1. Australia Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.2.2. Australia Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.3. Hong Kong Ophthalmology Drugs Market
      • 12.7.3.1. Hong Kong Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.4. India Ophthalmology Drugs Market
      • 12.7.4.1. India Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.4.2. India Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.5. Indonesia Ophthalmology Drugs Market
      • 12.7.5.1. Indonesia Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.5.2. Indonesia Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.6. Japan Ophthalmology Drugs Market
      • 12.7.6.1. Japan Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.6.2. Japan Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.7. Malaysia Ophthalmology Drugs Market
      • 12.7.7.1. Malaysia Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.8. New Zealand Ophthalmology Drugs Market
      • 12.7.8.1. New Zealand Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.9. Philippines Ophthalmology Drugs Market
      • 12.7.9.1. Philippines Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.10. Singapore Ophthalmology Drugs Market
      • 12.7.10.1. Singapore Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.11. South Korea Ophthalmology Drugs Market
      • 12.7.11.1. South Korea Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.11.2. South Korea Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.12. Thailand Ophthalmology Drugs Market
      • 12.7.12.1. Thailand Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.13. Vietnam Ophthalmology Drugs Market
      • 12.7.13.1. Vietnam Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

13. Western Europe Ophthalmology Drugs Market

  • 13.1. Western Europe Ophthalmology Drugs Market Overview
  • 13.2. Western Europe, Ophthalmology Drugs Market, 2019, By Country, Value ($ Billion)
  • 13.3. Western Europe, Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 13.4. Western Europe, Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 13.5. Western Europe, Ophthalmology Drugs Market Metrics
    • 13.5.1. Per Capita Average Ophthalmology Drugs Expenditure, 2015-2023, Western Europe Countries
  • 13.6. Western Europe Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 13.7. Western Europe Ophthalmology Drugs Market: Country Analysis
    • 13.7.1. Austria Ophthalmology Drugs Market
      • 13.7.1.1. Austria Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.2. Belgium Ophthalmology Drugs Market
      • 13.7.2.1. Belgium Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.3. Denmark Ophthalmology Drugs Market
      • 13.7.3.1. Denmark Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.4. Finland Ophthalmology Drugs Market
      • 13.7.4.1. Finland Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.5. France Ophthalmology Drugs Market
      • 13.7.5.1. France Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.5.2. France Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.6. Germany Ophthalmology Drugs Market
      • 13.7.6.1. Germany Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.6.2. Germany Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.7. Ireland Ophthalmology Drugs Market
      • 13.7.7.1. Ireland Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.8. Italy Ophthalmology Drugs Market
      • 13.7.8.1. Italy Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.9. Netherlands Ophthalmology Drugs Market
      • 13.7.9.1. Netherlands Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.10. Norway Ophthalmology Drugs Market
      • 13.7.10.1. Norway Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.11. Portugal Ophthalmology Drugs Market
      • 13.7.11.1. Portugal Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.12. Spain Ophthalmology Drugs Market
      • 13.7.12.1. Spain Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.13. Sweden Ophthalmology Drugs Market
      • 13.7.13.1. Sweden Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.14. Switzerland Ophthalmology Drugs Market
      • 13.7.14.1. Switzerland Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.15. UK Ophthalmology Drugs Market
      • 13.7.15.1. UK Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.15.2. UK Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

14. Eastern Europe Ophthalmology Drugs Market

  • 14.1. Eastern Europe Ophthalmology Drugs Market Overview
  • 14.2. Eastern Europe, Ophthalmology Drugs Market, 2019, By Country, Value ($ Billion)
  • 14.3. Eastern Europe, Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 14.4. Eastern Europe, Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 14.5. Eastern Europe, Ophthalmology Drugs Market Metrics
    • 14.5.1. Per Capita Average Ophthalmology Drugs Expenditure, 2015-2023, Eastern Europe Countries
  • 14.6. Eastern Europe Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 14.7. Eastern Europe Ophthalmology Drugs Market: Country Analysis
    • 14.7.1. Czech Republic Ophthalmology Drugs Market,
      • 14.7.1.1. Czech Republic Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.2. Poland Ophthalmology Drugs Market
      • 14.7.2.1. Poland Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.3. Romania Ophthalmology Drugs Market
      • 14.7.3.1. Romania Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.4. Russia Ophthalmology Drugs Market
      • 14.7.4.1. Russia Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 14.7.4.2. Russia Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

15. North America Ophthalmology Drugs Market

  • 15.1. North America Ophthalmology Drugs Market Overview
  • 15.2. North America, Ophthalmology Drugs Market, 2019, By Country, Value ($ Billion)
  • 15.3. North America, Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 15.4. North America, Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 15.5. North America, Ophthalmology Drugs Market Metrics
    • 15.5.1. Per Capita Average Ophthalmology Drugs Expenditure, 2015-2023, North America Countries
  • 15.6. North America Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 15.7. North America Ophthalmology Drugs Market: Country Analysis
    • 15.7.1. Canada Ophthalmology Drugs Market
      • 15.7.1.1. Canada Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 15.7.2. Mexico Ophthalmology Drugs Market
      • 15.7.2.1. Mexico Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 15.7.3. USA Ophthalmology Drugs Market
      • 15.7.3.1. USA Ophthalmology Drugs Market Overview
      • 15.7.3.2. USA Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 15.7.3.3. USA Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

16. South America Ophthalmology Drugs Market

  • 16.1. South America Ophthalmology Drugs Market Overview
  • 16.2. South America, Ophthalmology Drugs Market, 2019, By Country, Value ($ Billion)
  • 16.3. South America, Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 16.4. South America, Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 16.5. South America, Ophthalmology Drugs Market Metrics
    • 16.5.1. Per Capita Average Ophthalmology Drugs Expenditure, 2015-2023, South America Countries
  • 16.6. South America Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 16.7. South America Ophthalmology Drugs Market: Country Analysis
    • 16.7.1. Argentina Ophthalmology Drugs Market
      • 16.7.1.1. Argentina Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.2. Brazil Ophthalmology Drugs Market
      • 16.7.1.1. Brazil Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 16.7.2.2. Brazil Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.3. Chile Ophthalmology Drugs Market
      • 16.7.3.1. Chile Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.4. Colombia Ophthalmology Drugs Market
      • 16.7.4.1. Colombia Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.5. Peru Ophthalmology Drugs Market
      • 16.7.5.1. Peru Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.6. Venezuela Ophthalmology Drugs Market
      • 16.7.6.1. Venezuela Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

17. Middle East Ophthalmology Drugs Market

  • 17.1. Middle East Ophthalmology Drugs Market Overview
  • 17.2. Middle East, Ophthalmology Drugs Market, 2019, By Country, Value ($ Billion)
  • 17.3. Middle East, Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 17.4. Middle East, Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 17.5. Middle East, Ophthalmology Drugs Market Metrics
    • 17.5.1. Per Capita Average Ophthalmology Drugs Expenditure, 2015-2023, Middle East Countries
  • 17.6. Middle East Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 17.7. Middle East Ophthalmology Drugs Market: Country Analysis
    • 17.7.1. Saudi Arabia Ophthalmology Drugs Market
      • 17.7.1.1. Saudi Arabia Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.2. Israel Ophthalmology Drugs Market
      • 17.7.2.1. Israel Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.3. Turkey Ophthalmology Drugs Market
      • 17.7.3.1. Turkey Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.4. UAE Ophthalmology Drugs Market
      • 17.7.4.1. UAE Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

18. Africa Ophthalmology Drugs Market

  • 18.1. Africa Ophthalmology Drugs Market Overview
  • 18.2. Africa, Ophthalmology Drugs Market, 2019, By Country, Value ($ Billion)
  • 18.3. Africa, Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 18.4. Africa, Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 18.5. Africa, Ophthalmology Drugs Market Metrics
    • 18.5.1. Per Capita Average Ophthalmology Drugs Expenditure, 2015-2023, Africa Countries
  • 18.6. Africa Ophthalmology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 18.7. Africa Ophthalmology Drugs Market: Country Analysis
    • 18.7.1. Egypt Ophthalmology Drugs Market
      • 18.7.1.1. Egypt Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 18.7.2. Nigeria Ophthalmology Drugs Market
      • 18.7.2.1. Nigeria Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 18.7.3. South Africa Ophthalmology Drugs Market
      • 18.7.3.1. South Africa Ophthalmology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

19. Ophthalmology Drugs Market Competitive Landscape

  • 19.1. Competitive Market Overview
  • 19.2. Market Shares
  • 19.3. Company Profiles
    • 19.3.1. Novartis AG
      • 19.3.1.1. Company Overview
      • 19.3.1.2. Products And Services
      • 19.3.1.3. Strategy
      • 19.3.1.4. Financial Performance
    • 19.3.2. F. Hoffmann-La Roche Ltd
      • 19.3.2.1. Company Overview
      • 19.3.2.2. Products And Services
      • 19.3.2.3. Strategy
      • 19.3.2.4. Financial Performance
    • 19.3.3. Allergan Plc
      • 19.3.3.1. Company Overview
      • 19.3.3.2. Products And Services
      • 19.3.3.3. Strategy
      • 19.3.3.4. Financial Performance
    • 19.3.4. Valeant Pharmaceuticals Intl Inc
      • 19.3.4.1. Company Overview
      • 19.3.4.2. Products And Services
      • 19.3.4.3. Strategy
      • 19.3.4.4. Financial Performance
    • 19.3.5. Bayer AG
      • 19.3.5.1. Company Overview
      • 19.3.5.2. Products And Services
      • 19.3.5.3. Strategy
      • 19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Ophthalmology Drugs Market

21. Market Background: Pharmaceutical Drugs Market

  • 21.1. Pharmaceutical Drugs Market Characteristics
  • 21.2. Pharmaceutical Drugs Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F Growth, By Segment, Value ($ Billion), Global
  • 21.3. Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
  • 21.4. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • 21.5. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)

22. Recommendations

  • 22.1. Global Ophthalmology Drugs Market In 2023- Growth Countries
  • 22.2. Global Ophthalmology Drugs Market In 2023- Growth Segments
  • 22.3. Global Ophthalmology Drugs Market In 2023- Growth Strategies

23. Appendix

  • 23.1. NAICS Definitions Of Industry Covered In This Report
  • 23.2. Abbreviations
  • 23.3. Currencies
  • 23.4. Research Inquiries
  • 23.5. The Business Research Company

24. Copyright And Disclaimer